| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
Ingen historik.
| Branche | | Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n (649900). |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
Ingen historik.
| Revisionfravalgt | | false. |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | BioInnovation Institute Fonden. |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
Ingen historik.
| Binavne | | BII Foundation (Fond). |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
Ingen historik.
| Tegningsregel | | Fonden tegnes af (i) formanden i forening med enten en direktør eller to bestyrelsesmedlemmer eller (ii) næstformanden i forening med enten en direktør eller to bestyrelsesmedlemmer. |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
| Fortolkning
(4 tegningsmuligheder)
| | formanden + 1 direktør |
| formanden + 2 bestyrelsesmedlemmer |
| næstformanden + 1 direktør |
| næstformanden + 2 bestyrelsesmedlemmer |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Group in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion In our opinion, the Consolidated Financial Statements and the Parent Foundation Financial Statements give a true and fair view of the financial position of the Group and the Parent Foundation at 31 December 2022, and of the results of the Group’s and the Parent Foundation’s operations as well as the consolidated cash flows for the financial year 1 January - 31 December 2022 in accordance with the Danish Financial Statements Act. We have audited the Consolidated Financial Statements and the Parent Foundation Financial Statements of BioInnovation Institute Fonden for the financial year 1 January - 31 December 2022, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies, for both the Group and the Parent Foundation, as well as consolidated statement of cash flows (“financial statements”).
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review Management is responsible for Management’s Review. Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financials Statements Act. Based on the work we have performed, in our view, Management’s Review is in accordance with the Consolidated Financial Statements and the Parent Foundation Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement in Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Hjemmeside | | www.bioinnovationinstitute.com. |
| Sidst opdateret den 01.12.2020 og
angivet som gældende fra 01.12.2020 (1245
dage). |
Ingen historik.
LoginOpret gratis brugere-conomic integration